Literature DB >> 9174134

Biochemical analysis of plasma-soluble invariant chains and their complex formation with soluble HLA-DR.

V Rebmann1, K Dornmair, H Grosse-Wilde.   

Abstract

The invariant chain (CD74) is preferentially localized in the cytoplasm and regulates the loading of exogenous derived peptides into HLA class II heterodimers. In addition, a small proportion of CD74:class II complexes is also expressed on the cell surface. We identified and quantified soluble CD74 (sCD74) molecules in the plasma and sCD74:sHLA-DR complexes by ELISA. EDTA plasma samples from 86 healthy probands were analyzed. sCD74 could be detected in all samples with a mean concentration of 1.14 relative units +/- 1.04 SD (range 0.17-4.31). Approximately 10% of the samples had increased amounts of sCD74 (>3.0 relative units). Complexes of sCD74 and sHLA-DR were detected in all samples and their quantities were positively correlated (r=0.83, p<0.001) with the sCD74 concentrations. SDS-PAGE analysis of plasma samples with high sCD74 concentrations (>3.0 relative units) revealed four isoforms of sCD74 with molecular weights of 45, 43, 35, 31 kDa corresponding to known sizes of intracellular CD74. However, only molecular weights of the 45 and 43 kDa isoforms of sCD74 are found complexed with sHLA-DR. Our data demonstrate, that CD74 molecules are present in their soluble form in the plasma of healthy probands and form complexes with soluble HLA-DR molecules.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9174134     DOI: 10.1111/j.1399-0039.1997.tb02776.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  4 in total

Review 1.  Interplay between T helper type 1 and type 2 cytokines and soluble major histocompatibility complex molecules: a paradigm in pregnancy.

Authors:  Irene Athanassakis; S Vassiliadis
Journal:  Immunology       Date:  2002-11       Impact factor: 7.397

2.  CD74-Downregulation of Placental Macrophage-Trophoblastic Interactions in Preeclampsia.

Authors:  Lukasz Przybyl; Nadine Haase; Michaela Golic; Julianna Rugor; Maria Emilia Solano; Petra Clara Arck; Martin Gauster; Berthold Huppertz; Christoph Emontzpohl; Christian Stoppe; Jürgen Bernhagen; Lin Leng; Richard Bucala; Herbert Schulz; Arnd Heuser; M Susanne Weedon-Fekjær; Guro M Johnsen; Dirk Peetz; Friedrich C Luft; Anne Cathrine Staff; Dominik N Müller; Ralf Dechend; Florian Herse
Journal:  Circ Res       Date:  2016-05-19       Impact factor: 17.367

3.  Interplay between soluble CD74 and macrophage-migration inhibitory factor drives tumor growth and influences patient survival in melanoma.

Authors:  Yasunari Fukuda; Matias A Bustos; Sung-Nam Cho; Jason Roszik; Suyeon Ryu; Victor M Lopez; Jared K Burks; Jeffrey E Lee; Elizabeth A Grimm; Dave S B Hoon; Suhendan Ekmekcioglu
Journal:  Cell Death Dis       Date:  2022-02-04       Impact factor: 9.685

4.  The Proinflammatory and Proangiogenic Macrophage Migration Inhibitory Factor Is a Potential Regulator in Proliferative Diabetic Retinopathy.

Authors:  Ahmed M Abu El-Asrar; Ajmal Ahmad; Mohammad Mairaj Siddiquei; Alexandra De Zutter; Eef Allegaert; Priscilla W Gikandi; Gert De Hertogh; Jo Van Damme; Ghislain Opdenakker; Sofie Struyf
Journal:  Front Immunol       Date:  2019-12-04       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.